Cargando…
Essential updates 2021/2022: Surgical outcomes of oligometastasis in pancreatic ductal adenocarcinoma
Oligometastatic disease has been proposed as an intermediate state between localized and polymetastatic disease that can benefit from multimodal treatment, including surgery. There is a growing concern about performing surgery for oligometastatic pancreatic ductal adenocarcinoma, although there is s...
Autores principales: | Yasuda, Satoshi, Nagai, Minako, Terai, Taichi, Kohara, Yuichiro, Sho, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154895/ https://www.ncbi.nlm.nih.gov/pubmed/37152775 http://dx.doi.org/10.1002/ags3.12655 |
Ejemplares similares
-
Importance of triple tumor markers as biomarkers in patients with pancreatic ductal adenocarcinoma
por: Takagi, Tadataka, et al.
Publicado: (2022) -
Pancreatic ductal adenocarcinoma arising from the pancreatic parenchyma compressed by a huge pancreatic lipoma: a case report
por: Nakahara, Seiji, et al.
Publicado: (2023) -
Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report
por: Matsuki, Ryota, et al.
Publicado: (2018) -
Diagnosis of oligometastasis
por: Terao, Mayako, et al.
Publicado: (2020) -
Phase II Study of the Triple Combination Chemotherapy of SOXIRI (S‐1/Oxaliplatin/Irinotecan) in Patients with Unresectable Pancreatic Ductal Adenocarcinoma
por: Akahori, Takahiro, et al.
Publicado: (2019)